Abstract:Aim of review: Neuropathic pain (NPP), a common clinical condition, is characterized by allodynia and hyperalgesia. In the setting of NPP, components in the peripheral and central transmission pathway of pain exhibit tremendous plasticity, facilitating pain signal conduction and giving rise to hypersensitivity. Clarifying the signal path of nociceptive processing and discovering the key molecules involved in NPP may allow improvement of its treatment.Method: This article reviewed the sphingosine-1-phosphate (S1P) and sphingosine-1-phosphate receptors (S1PRs) alliance that initiates and maintains peripheral and central sensitization in NPP, underlying the fundamental contribution and multiple mechanisms of this alliance in synaptic plasticity.Recent findings: In the peripheral nervous system, S1P-S1PRs alliance contributes to the inflammatory chemical milieu formation and ion channel function, which increase the ectopic action potentials of sensory neurons. In addition, S1P-S1PRs alliance affects thermal hyperalgesia through enhancing inward tetrodotoxin-resistant INa+ and decreasing total outward IK+ on the nociceptors. In the central nervous system, S1P-S1PRs alliance facilitates the neuroinflammatory response and glutamate accumulation at the first pain synapse, which leads to persistent central hypersensitization. Furthermore, S1P-S1PRs alliance could disequilibrate the extracellular glutamate via reducing the activities of glutamine synthetase (GS) and glutamate transporters (GTs), which are the key players in glutamate metabolism.Summary: Targeting S1P-S1PRs alliance may be an Achilles' heel of the Trojan horse model of NPP. Citation: Jin-Chao Hou, Xiang-Ming Fang. S1P-S1PRs alliance in neuropathic pain processing. J Anesth Perioper Med 2015; 2: 87-95. doi: 10.24015/JAPM.2015.0013This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

SUMOylation and DeSUMOylation: Tug of War of Pain Signaling

SUMOylation of Kir7.1 Participates in Neuropathic Pain Through Regulating Its Membrane Expression in Spinal Cord Neurons.

SUMO regulation of ion channels in health and disease

Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory.

S1P-S1PRs Alliance in Neuropathic Pain Processing

TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain

SUMOylation and Potassium Channels: Links to Epilepsy and Sudden Death

SUMOylation: A Link to Future Therapeutics.

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

Optogenetic and Chemogenic Control of Pain Signaling: Molecular Markers

SUMO proteases: from cellular functions to disease

Mini-review - Sodium Channels and Beyond in Peripheral Nerve Disease: Modulation by Cytokines and Their Effector Protein Kinases.

Ionotropic glutamate receptors contribute to pain transmission and chronic pain

PKCε SUMOylation Is Required for Mediating the Nociceptive Signaling of Inflammatory Pain

Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain

Ion Channel Genes in Painful Neuropathies

Research Progress of Sumoylation in the Regeneration of Peripheral Nerve Injury

Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation

Regulating excitability of peripheral afferents: emerging ion channel targets

Role of TRPM Channels in Pain States

Variation in Expression of Small Ubiquitin-Like Modifiers in Injured Sciatic Nerve of Mice